Zobrazeno 1 - 10
of 29
pro vyhledávání: '"GJ Moyle"'
Publikováno v:
HIV Medicine. 6:185-190
Background Adherence to antiretroviral therapy is critical to treatment outcomes. Adherence studies in other therapeutic areas of medicine suggest that once-daily regimens support improved adherence when compared to twice-daily therapy. An expansion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb5798e609e1d40270bf5aef98ca889
https://doi.org/10.1111/j.1468-1293.2005.00287.x
https://doi.org/10.1111/j.1468-1293.2005.00287.x
Autor:
BG Gazzard, GJ Moyle, J Weber, M Johnson, JS Bingham, R Brettle, D Churchill, M Fisher, G Griffin, D Jefferies, E King, R Gormer, C Lee, A Pozniak, JR Smith, G Tudor-Williams, I Williams
Publikováno v:
The Lancet. 349:1086-1092
Summary Only incomplete data are available to guide decisions on anti-HIV treatment. A British HIV Association consensus is that guidance must draw on other evidence besides the randomised trial. Marker studies, work on disease pathogenesis and viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7cbeec16bd90d9152caf2c8fe4a5652
https://doi.org/10.1016/s0140-6736(96)12073-0
https://doi.org/10.1016/s0140-6736(96)12073-0
Autor:
GJ Moyle
Publikováno v:
Expert opinion on investigational drugs. 6(8)
Massive viral turnover and reverse transcriptase's high error rate create the potential for drug-resistant viral variants to appear rapidly under the selective pressure of antiretroviral therapy. Loss of antiviral effect in treatment-adherent persons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41f902210402e682c8eef7e86c505f4
https://pubmed.ncbi.nlm.nih.gov/15989655
https://pubmed.ncbi.nlm.nih.gov/15989655
Publikováno v:
Europe PubMed Central
The time from the recognition that AIDS was an infectious disease, to the discovery of HIV as the causative agent and the identification of the first specific antiviral agent that showed some clinical benefit, was impressively short. Over the last fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c1331e5e108e197fa22b5dfd0bf480c0
https://pubmed.ncbi.nlm.nih.gov/7552939
https://pubmed.ncbi.nlm.nih.gov/7552939
Autor:
BG Gazzard, GJ Moyle
Publikováno v:
The British journal of clinical practice. 49(3)
Assessment of clinical and laboratory markers of HIV infection may be used to individualise antiretroviral therapy. Data suggest that measures of viral load may be of considerable value as both a baseline and dynamic therapy marker, making these tool
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5ad9687225c64229e94060b0e758018
https://pubmed.ncbi.nlm.nih.gov/7779666
https://pubmed.ncbi.nlm.nih.gov/7779666
Publikováno v:
Journal of the International AIDS Society. 11(Suppl 1):P98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57274e928e411b4622cedcd448e08bac
Autor:
Maitland, D1, Jackson, A1, Osorio, J1, Mandalia, S1, Gazzard, BG1, Moyle, GJ1 gm@moyleg.demon.co.uk
Publikováno v:
HIV Medicine. Sep2008, Vol. 9 Issue 8, p667-672. 6p. 3 Charts, 1 Graph.
Publikováno v:
HIV Medicine. Apr2006, Vol. 7 Issue 3, p181-185. 5p. 3 Charts, 1 Graph.
Autor:
Jones, R.1 rachaeljones30@hotmail.com, Sawleshwarkar, S.1, Michailidis, C.1, Jackson, A.1, Mandalia, S.1, Stebbing, J.1, Bower, M.1, Nelson, M.1, Gazzard, B. G.1, Moyle, G. J.1
Publikováno v:
HIV Medicine. Nov2005, Vol. 6 Issue 6, p396-402. 7p.
Publikováno v:
HIV Medicine. May2005 Supplement 1, Vol. 6 Issue s1, p14-55. 42p.